(HealthDay News) — Use of phosphodiesterase type 5 (PDE5) inhibitors does not appear to increase the risk of melanoma, according to the conclusions of a meta-analysis published online in the Journal ...

In at least one study, regular long-term use of sildenafil was shown to improve left ventricle function while strengthening the structure of a failing left ventricle. Sildenafil’s role as a PDE5 ...

Phosphodiesterase 5 (PDE5) inhibitors (eg, sildenafil, tadalafil) do not appear to reduce the risk of Alzheimer disease and related dementias, according to a National Institutes of Health (NIH) study.

There is a class of drugs called “Phosphodiesterase-5 inhibitors” (PDE5 inhibitors.) Such drugs in this class are known as sildenafil, vardenafil, tadalafil, and avanafil.1 These drugs all work by ...

Conventional dendritic cells (cDCs) are antigen-presenting cells critical to antitumour immunity. A cDC subset, migratory cDCs (mig-cDCs), travel through lymphatic vessels from the tumour ...

Nicox SA has entered into an exclusive research and license option agreement with Glaukos Corp. for NCX-1728, Nicox’s novel nitric oxide (NO)-donating phosphodiesterase PDE5 inhibitor. NCX-1728 is the ...

Please provide your email address to receive an email when new articles are posted on . Men with CAD who combined nitrates with common ED drugs were at higher risk for death and adverse CV events. The ...

Rugiet Ready combines FDA-approved active ingredients found in other erectile dysfunction (ED) medications, along with a dopamine promoter, into a custom-formulated, easy-to-take dissolvable treatment ...